Acute Otitis Media: Adjuvant Therapy to Improve Outcome
Study Details
Study Description
Brief Summary
Acute otitis media is one of the most common diseases of childhood and is one of the major causes of hearing loss in children. Despite the availability of effective antibiotic therapy for otitis media, treatment failures, persistent effusions, and recurrences are common. This Phase III outpatient study aims to test whether adjuvant therapy (an antihistamine or a corticosteroid), in addition to antibiotic therapy, improves the acute and long-term outcomes of patients with acute otitis media. This study is targeted to recruiting 200 infants (age less than one year); patient (and parent) participation is estimated to continue for one year after enrollment.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 3 |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Have had two documented prior episodes of acute otitis media.
-
Have no current middle ear effusion (fluid).
Exclusion Criteria:
-
Have chronic otitis media.
-
Have acute otitis media in addition to chronic otitis media.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ of Texas Med Branch Children's Hosp | Galveston | Texas | United States | 77550 |
Sponsors and Collaborators
- National Institute on Deafness and Other Communication Disorders (NIDCD)
Investigators
- Study Chair: Dr. Tasnee Chonmaitree,
Study Documents (Full-Text)
None provided.More Information
Publications
- Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, McCormick DP. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003 Sep;143(3):377-85.
- McCormick DP, Saeed K, Uchida T, Baldwin CD, Deskin R, Lett-Brown MA, Heikkinen T, Chonmaitree T. Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol. 2003 Mar;67(3):221-30.
- NIDCD-1160
- R01DC002620-04